Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Infect Dis ; 144: 107053, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38641317

ABSTRACT

BACKGROUND: Vietnam continues to have measles and rubella outbreaks following supplementary immunization activities (SIA) and routine immunization despite both having high reported coverage. To evaluate immunization activities, age-specific immunity against measles and rubella, and the number of averted Congenital Rubella Syndrome (CRS) cases, must be estimated. METHODS: Dried blood spots were collected from 2091 randomly selected individuals aged 1-39 years. Measles and rubella virus-specific immunoglobulin G (IgG) were measured by enzyme immunoassay. Results were considered positive at ≥120 mIU/mL for measles and ≥10 IU/mL for rubella. The number of CRS cases averted by immunization since 2014 were estimated using mathematical modelling. RESULTS: Overall IgG seroprevalence was 99.7% (95%CI: 99.2-99.9) for measles and 83.6% (95%CI: 79.3-87.1) for rubella. Rubella IgG seroprevalence was higher among age groups targeted in the SIA than in non-targeted young adults (95.4% [95%CI: 92.9-97.0] vs 72.4% [95%CI: 63.1-80.1]; P < 0.001). The estimated number of CRS cases averted in 2019 by immunization activities since 2014 ranged from 126 (95%CI: 0-460) to 883 (95%CI: 0-2271) depending on the assumed postvaccination reduction in the force of infection. CONCLUSIONS: The results suggest the SIA was effective, while young adults born before 1998 who remain unprotected for rubella require further vaccination.


Subject(s)
Antibodies, Viral , Immunoglobulin G , Measles , Rubella , Humans , Immunoglobulin G/blood , Measles/epidemiology , Measles/prevention & control , Measles/immunology , Adolescent , Child, Preschool , Child , Rubella/epidemiology , Rubella/immunology , Rubella/prevention & control , Adult , Male , Seroepidemiologic Studies , Female , Young Adult , Infant , Antibodies, Viral/blood , Models, Theoretical , Rubella Vaccine/immunology , Rubella Vaccine/administration & dosage , Rubella virus/immunology , Prevalence , Measles Vaccine/immunology , Measles Vaccine/administration & dosage , Age Factors , Vaccination , Immunization Programs , Rubella Syndrome, Congenital/epidemiology , Rubella Syndrome, Congenital/prevention & control , Rubella Syndrome, Congenital/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...